RecruitingPhase 3NCT06671483
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines
Sponsor: Takeda
Chandler, AZ · Phoenix, AZ · +50 more sites
Phase 3 Psoriasis clinical trials
12 recruiting Phase 3 psoriasis studies in the US. What trial phases mean
Other phases
RecruitingPhase 3NCT07116967
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
Sponsor: Bristol-Myers Squibb
Birmingham, AL · Phoenix, AZ · +119 more sites
RecruitingPhase 3NCT06663332
A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
Sponsor: Janssen Research & Development, LLC
Atlanta, GA · Indianapolis, IN · +3 more sites
RecruitingPhase 3NCT06807424
A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced and Biologic-naive Participants With Active Psoriatic Arthritis
Sponsor: Janssen Research & Development, LLC
Glendale, AZ · Mesa, AZ · Jonesboro, AR · +22 more sites
RecruitingPhase 3NCT07362017
Open Label Study to Investigate the Safety and Efficacy of Ponesimod in Moderate-to-Severe Chronic Plaque Psoriasis
Sponsor: Vanda Pharmaceuticals
Glendale, AZ · Fremont, CA · Miami, FL · +7 more sites
RecruitingPhase 3NCT07250802
A Long-Term Study of Zasocitinib in Children and Teenagers With Plaque Psoriasis
Sponsor: Takeda
Chula Vista, CA · Fountain Valley, CA · Hialeah, FL · +8 more sites
RecruitingPhase 3NCT07286058
Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis
Sponsor: Takeda
Tucson, AZ · Fountain Valley, CA · La Mesa, CA · +16 more sites
RecruitingPhase 3NCT06979453
A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis
Sponsor: Bristol-Myers Squibb
Birmingham, AL · Phoenix, AZ · +44 more sites
RecruitingPhase 3NCT06100744
A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab
Sponsor: AbbVie
Little Rock, AR · Washington D.C., DC · Hollywood, FL · +9 more sites
RecruitingPhase 3NCT07219420
A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Palmoplantar Pustulosis
Sponsor: UCB Biopharma SRL
Birmingham, AL · Fremont, CA · Miami, FL · +5 more sites
RecruitingPhase 3NCT07426120
Efficacy and Safety of a Botanical Total Coumarin (TC) Cream in Treating Patients With Psoriasis Vulgaris (PLANTCOAT-III)
Sponsor: Psoriasis Research Institute of Guangzhou
New York, NY
RecruitingPhase 3NCT05669833
Guselkumab vs Golimumab in PsA TNF Inadequate Responder Patients
Sponsor: University of Pennsylvania
Loxahatchee Groves, FL · Plant City, FL · Riverview, FL · +11 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.